Compounded Oral Tirzepatide is a prescription medication prepared by a licensed compounding pharmacy and prescribed only when a licensed provider determines it’s appropriate.
At Josie, oral tirzepatide comes as a rapid dissolve tablet, also called an RDT. It’s taken by mouth as directed by your provider and is designed for women who prefer an oral option instead of injections.
This care path starts with an intake form and provider review. Your provider looks at your health history, medications, goals, risk factors, and current concerns before deciding whether compounded oral tirzepatide fits your plan.
This isn’t a one-size-fits-all product. It’s prescription care, and your provider determines the dose, follow-up plan, and next steps based on your individual profile.
Some women want GLP-1 support but don’t want injections.
A compounded oral RDT may be considered for eligible patients who prefer:
Oral compounded tirzepatide is different from injectable GLP-1 options. Route, formulation, absorption, dosing, and response may vary. Your provider can help explain the differences and decide which care path makes sense for you.
Tirzepatide is related to two hormone pathways commonly referred to as GLP-1 and GIP. These pathways are involved in appetite signaling, feelings of fullness, and glucose regulation.
A licensed provider may consider tirzepatide-based care when weight-related support is appropriate after reviewing a patient’s full health profile.
This medication isn’t a shortcut, and it’s not appropriate for everyone. It should be used with provider guidance and paired with habits like nutrition, movement, sleep, and follow-up care.
Josie provides provider-led hormone and weight management care for women in perimenopause, menopause, and postmenopause.
Many women in midlife are dealing with more than one change at once: appetite shifts, sleep issues, body composition changes, hormone symptoms, stress, and a body that doesn’t respond the way it used to.
Josie’s care model starts with provider review so the plan fits the person, not just the product.
1. Complete Your Intake Form
You’ll answer questions about your health history, goals, medications, and current concerns.
2. Provider Review
A licensed provider reviews your information to decide whether treatment may be appropriate.
3. Prescription, If Appropriate
When prescribed, your medication is prepared by a licensed compounding pharmacy.
4. Delivery
Medication is shipped to your door after processing.
5. Ongoing Support
Your provider can guide dose changes, follow-ups, and next steps based on your response.
Not sure whether an oral option or injections make more sense? Compare it below:
Oral and injectable GLP-1 options are not the same. They may differ in route, formulation, absorption, dosing approach, patient experience, and provider monitoring.
Your provider can help explain these differences before prescribing and determine whether an oral option, injectable option, or different care path is more appropriate.
Compounded Oral Tirzepatide is a prescription medication and should only be used under the supervision of a licensed healthcare provider.
Tirzepatide-based therapies aren’t appropriate for everyone. Your provider will review your health history, medications, allergies, risk factors, pregnancy plans, breastfeeding status, prior reactions to GLP-1 medications, gallbladder history, pancreatitis history, gastrointestinal conditions, and any side effects or concerns before deciding whether treatment is appropriate.
Results vary. Treatment isn’t guaranteed to cause weight loss or any specific outcome.
Always follow your provider’s instructions and report side effects or concerns.
Compounded Oral Tirzepatide is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they’re marketed. This medication may be prescribed only after a licensed provider reviews your health history and determines whether it’s appropriate. The prescription may be filled by a licensed compounding pharmacy. Josie is not the compounding pharmacy.
No. Women in perimenopause, menopause, postmenopause, and other midlife stages may complete an intake form. Your provider determines whether treatment is appropriate based on your health history and goals.
No. Josie’s oral tirzepatide option is compounded and is not FDA-approved.
No. Oral tirzepatide and injectable GLP-1 options may differ in route, formulation, absorption, dosing, patient experience, and provider monitoring.
Response varies. Some patients may notice appetite-related changes earlier than others, while weight-related changes may take longer and depend on the full care plan. No result is guaranteed.
Oral RDTs may be easier to travel with than injections because there are no needles or sharps. Always follow the pharmacy’s storage and handling instructions.
Your provider can review your response and determine whether a dose change or different care path makes sense.
Yes. Plans are month-to-month. Patients must complete the required refill process to continue receiving medication.
Your provider can help review your experience and discuss next steps, which may include continuing oral treatment, changing the care plan, or considering another option.
Compounded Oral Tirzepatide may be an option for eligible women who want GLP-1 support without injections.
Complete your intake form to see whether this care path may fit your health history, goals, and provider-reviewed plan.
Compounded Oral Tirzepatide is a prescription medication prepared by a licensed compounding pharmacy and prescribed only when a licensed provider determines it’s appropriate.
At Josie, oral tirzepatide comes as a rapid dissolve tablet, also called an RDT. It’s taken by mouth as directed by your provider and is designed for women who prefer an oral option instead of injections.
This care path starts with an intake form and provider review. Your provider looks at your health history, medications, goals, risk factors, and current concerns before deciding whether compounded oral tirzepatide fits your plan.
This isn’t a one-size-fits-all product. It’s prescription care, and your provider determines the dose, follow-up plan, and next steps based on your individual profile.
Some women want GLP-1 support but don’t want injections.
A compounded oral RDT may be considered for eligible patients who prefer:
Oral compounded tirzepatide is different from injectable GLP-1 options. Route, formulation, absorption, dosing, and response may vary. Your provider can help explain the differences and decide which care path makes sense for you.
Tirzepatide is related to two hormone pathways commonly referred to as GLP-1 and GIP. These pathways are involved in appetite signaling, feelings of fullness, and glucose regulation.
A licensed provider may consider tirzepatide-based care when weight-related support is appropriate after reviewing a patient’s full health profile.
This medication isn’t a shortcut, and it’s not appropriate for everyone. It should be used with provider guidance and paired with habits like nutrition, movement, sleep, and follow-up care.
Josie provides provider-led hormone and weight management care for women in perimenopause, menopause, and postmenopause.
Many women in midlife are dealing with more than one change at once: appetite shifts, sleep issues, body composition changes, hormone symptoms, stress, and a body that doesn’t respond the way it used to.
Josie’s care model starts with provider review so the plan fits the person, not just the product.
1. Complete Your Intake Form
You’ll answer questions about your health history, goals, medications, and current concerns.
2. Provider Review
A licensed provider reviews your information to decide whether treatment may be appropriate.
3. Prescription, If Appropriate
When prescribed, your medication is prepared by a licensed compounding pharmacy.
4. Delivery
Medication is shipped to your door after processing.
5. Ongoing Support
Your provider can guide dose changes, follow-ups, and next steps based on your response.
Not sure whether an oral option or injections make more sense? Compare it below:
Oral and injectable GLP-1 options are not the same. They may differ in route, formulation, absorption, dosing approach, patient experience, and provider monitoring.
Your provider can help explain these differences before prescribing and determine whether an oral option, injectable option, or different care path is more appropriate.
Compounded Oral Tirzepatide is a prescription medication and should only be used under the supervision of a licensed healthcare provider.
Tirzepatide-based therapies aren’t appropriate for everyone. Your provider will review your health history, medications, allergies, risk factors, pregnancy plans, breastfeeding status, prior reactions to GLP-1 medications, gallbladder history, pancreatitis history, gastrointestinal conditions, and any side effects or concerns before deciding whether treatment is appropriate.
Results vary. Treatment isn’t guaranteed to cause weight loss or any specific outcome.
Always follow your provider’s instructions and report side effects or concerns.
Compounded Oral Tirzepatide is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they’re marketed. This medication may be prescribed only after a licensed provider reviews your health history and determines whether it’s appropriate. The prescription may be filled by a licensed compounding pharmacy. Josie is not the compounding pharmacy.
No. Women in perimenopause, menopause, postmenopause, and other midlife stages may complete an intake form. Your provider determines whether treatment is appropriate based on your health history and goals.
No. Josie’s oral tirzepatide option is compounded and is not FDA-approved.
No. Oral tirzepatide and injectable GLP-1 options may differ in route, formulation, absorption, dosing, patient experience, and provider monitoring.
Response varies. Some patients may notice appetite-related changes earlier than others, while weight-related changes may take longer and depend on the full care plan. No result is guaranteed.
Oral RDTs may be easier to travel with than injections because there are no needles or sharps. Always follow the pharmacy’s storage and handling instructions.
Your provider can review your response and determine whether a dose change or different care path makes sense.
Yes. Plans are month-to-month. Patients must complete the required refill process to continue receiving medication.
Your provider can help review your experience and discuss next steps, which may include continuing oral treatment, changing the care plan, or considering another option.
Compounded Oral Tirzepatide may be an option for eligible women who want GLP-1 support without injections.
Complete your intake form to see whether this care path may fit your health history, goals, and provider-reviewed plan.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript